Survey, laboratory and statistical methods for the BSAC Resistance Surveillance Programmes
Open Access
- 1 November 2008
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 62 (Supplement) , ii15-ii28
- https://doi.org/10.1093/jac/dkn349
Abstract
The British Society for Antimicrobial Chemotherapy (BSAC) Bacteraemia and Respiratory Resistance Surveillance Programmes are designed for long-term surveillance of antimicrobial resistance in key pathogens of bloodstream and community-acquired respiratory infection in the UK and Ireland. This paper describes their methods in detail. Sentinel laboratories across the UK and Ireland contributed up to a fixed quota of isolates of defined bacterial groups. Collecting laboratories were compared with national benchmarks for size of Hospital Trust and distribution of bacteraemia pathogens. A central laboratory for each programme confirmed the identification of isolates, measured MICs by the BSAC agar dilution method and undertook further testing by standard methods. The variability of the MIC method was assessed by repeated annual testing of a panel of control isolates. Classification as susceptible, intermediate or resistant was by BSAC and European Committee on Antimicrobial Susceptibility Testing breakpoints. Statistical analysis was adjusted for inter-centre variation using random effects logistic regression. Thirty-two laboratories contributed 16 550 respiratory isolates from 1999–2000 to 2006–07; 30 laboratories contributed 15 812 bacteraemia isolates from 2001 to 2006. Although large and teaching hospitals were over-represented, the pattern of bacteraemia organisms seen in the collecting laboratories in England and Wales was similar to that in national data reported to the Health Protection Agency. Replicate MIC measurements showed that ≥90% agreed within ±1, and ≥98% within ±2, doubling dilutions. These surveillance programmes have provided reliable information on antimicrobial susceptibility in the UK and Ireland over six and eight seasons, respectively, so far. Detailed results showing non-susceptibility trends, and relationships with potential predictive factors, are presented in six linked papers in this Supplement.Keywords
This publication has 26 references indexed in Scilit:
- The British Society for Antimicrobial Chemotherapy Resistance Surveillance Project: a successful collaborative modelJournal of Antimicrobial Chemotherapy, 2008
- Non-susceptibility trends among enterococci and non-pneumococcal streptococci from bacteraemias in the UK and Ireland, 2001-06Journal of Antimicrobial Chemotherapy, 2008
- Analysis, power and design of antimicrobial resistance surveillance studies, taking account of inter-centre variation and turnoverJournal of Antimicrobial Chemotherapy, 2008
- Multiplex PCR for rapid detection of genes encoding CTX-M extended-spectrum β-lactamasesJournal of Antimicrobial Chemotherapy, 2005
- False-positive extended-spectrum -lactamase tests for Klebsiella oxytoca strains hyperproducing K1 -lactamaseJournal of Antimicrobial Chemotherapy, 2004
- A study of small-colony, β-haemolytic, Lancefield group C streptococci within the anginosus group: description of Streptococcus constellatus subsp. pharyngis subsp. nov., associated with the human throat and pharyngitisInternational Journal of Systematic and Evolutionary Microbiology, 1999
- Heterogeneous location of the mupA high-level mupirocin resistance gene in Staphylococcus aureusJournal of Medical Microbiology, 1998
- Rapid identification by specific PCR of coagulase-negative staphylococcal species important in hospital infectionJournal of Medical Microbiology, 1997
- Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistanceJournal of Antimicrobial Chemotherapy, 1996
- A scheme for the identification of viridans streptococciJournal of Medical Microbiology, 1991